The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

A growing number of women are turning to testosterone treatments to ease their menopause symptoms — and save their sex lives.

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

It is being widely touted anecdotally as a solution to everything from low libido to brain fog and fatigue. Still, experts ...

The US health officials expanded approval of the libido-boosting drug Addyi for post-menopausal women Our experts share its ...

Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...

President Donald Trump signed an executive order in the Oval Office of the White House on Thursday that will reschedule ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.

Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in women who are ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Accessing Testosterone Replacement Therapy shouldn’t make you ...